Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts.

Pingping YanYu DongFenfen ZhangTiantian ZhenJiangtao LiangHuijuan ShiAnjia Han

Published in: Journal of clinical pathology (2024)

Our results suggest claudin18.2 might be a potential biomarker for targeted therapy on lung mucinous adenocarcinoma, cholangiocarcinoma, colorectal mucinous adenocarcinoma and gastric-type cervical adenocarcinoma.

Keyphrases

squamous cell carcinoma
locally advanced
low grade
poor prognosis
machine learning
radiation therapy
deep learning